When in the drug development process should we start thinking about a (companion) diagnostic strategy?

As the (companion) diagnostic strategy can affect the pharmacological strategy and impact timelines for clinical trail applications, it is recommended to start as early as possible. GenDx recommends to contact us prior to or when planning Phase 1 trials, as we may be able to support you during this phase too.